Clinical trial
Gabapentin to Treat Itch in Patients With Liver Disease
NCT00058890 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00058890 |
|---|---|
| Title | Gabapentin to Treat Itch in Patients With Liver Disease |
| Official title | Study of Gabapentin for the Pruritus of Cholestasis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Disease, Cholestasis, Cirrhosis, Pruritus, Itching |
| Intervention type | Drug |
| Interventions | Gabapentin, Placebo |
| Enrollment | 15 |
| Start date | Nov 1, 2000 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Apr 16, 2003 |
| Last update posted | Oct 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: